Literature DB >> 31150989

STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.

Yun-Xia An1, Yi-Jun Shang1, Zhi-Wei Xu1, Qun-Cheng Zhang1, Zheng Wang1, Wei-Xia Xuan1, Xiao-Ju Zhang2.   

Abstract

Long noncoding RNAs (lncRNAs) have been demonstrated to play significant roles in non-small cell lung cancer (NSCLC) progression. Recently, a newly identified lncRNA, LncRNA LINC00668 (LINC00668), was reported to be involved in the regulation of progression of several tumors. However, the expression pattern and biological function of LINC00668 in NSCLC remains largely unclear. In this study, we found that LINC00668 expression was significantly up-regulated in both NSCLC tissues and cell lines. we also showed that LINC00668 upregulation was induced by transcription factor STAT3. Clinical investigation demonstrated that high expression level of LINC00668 was associated with advanced TNM stage, histological grade and lymph node metastasis. Moreover, multivariate analysis confirmed LINC00668 expression level to be an independent prognostic indicator for overall survival of NSCLC patients. Functional assays indicated that knockdown of LINC00668 suppressed NSCLC cells proliferation, migration and invasion, and promoted apoptosis. Mechanistic studies indicated that LINC00668 is a direct target of miR-193a, leading to down-regulation in the expression of its target gene KLF7. Our findings suggested that STAT3-induced LINC00668 contributed to NSCLC progression through upregulating KLF7 expression by sponging miR-193a, and may serve as a prognostic biomarker and a potential target for NSCLC.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  KLF7; LncRNA LINC00668; Non-small cell lung cancer; Prognosis; STAT3; miR-193a

Mesh:

Substances:

Year:  2019        PMID: 31150989     DOI: 10.1016/j.biopha.2019.109023

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  12 in total

1.  KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity.

Authors:  Romi Gupta; Parmanand Malvi; Keshab Raj Parajuli; Radoslav Janostiak; Suresh Bugide; Guoping Cai; Lihua Julie Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

2.  MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.

Authors:  Ke Li; Conghu Yuan
Journal:  Int J Mol Med       Date:  2020-06-18       Impact factor: 4.101

3.  LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway.

Authors:  Xueke Lin; Dilu Feng; Ping Li; Yuchun Lv
Journal:  Cancer Med       Date:  2020-09-12       Impact factor: 4.452

4.  GNA14 stimulation of KLF7 promotes malignant growth of endometrial cancer through upregulation of HAS2.

Authors:  Jing Wang; Fei Teng; Hongxia Chai; Caixia Zhang; Xiaolei Liang; Yongxiu Yang
Journal:  BMC Cancer       Date:  2021-04-23       Impact factor: 4.430

5.  The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Juan Wang; Xu Han; Ye Yuan; Hao Gu; Xing Liao; Miao Jiang
Journal:  Front Genet       Date:  2022-04-05       Impact factor: 4.772

6.  [LINC00668 is Highly Expressed in Lung Squamous Cell Carcinoma and 
Promotes Tumor Cell Migration and Invasion].

Authors:  Bo Yuan; Yang Chen; Jingyan Yuan; Lizhong Zeng; Shuanying Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-04-20

7.  MicroRNA-136-3p inhibits glioma tumorigenesis in vitro and in vivo by targeting KLF7.

Authors:  Yanwu Xu
Journal:  World J Surg Oncol       Date:  2020-07-16       Impact factor: 2.754

8.  LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.

Authors:  Wei Xuan; Chen Zhou; Guangqiang You
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 9.  Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application.

Authors:  Yuan-Xiang Shi; De-Qiao Sheng; Lin Cheng; Xin-Yu Song
Journal:  J Oncol       Date:  2019-12-12       Impact factor: 4.375

10.  Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1.

Authors:  Hongbo Wu; Xiaoqian Mu; Lei Liu; Huijuan Wu; Xiufeng Hu; Lijuan Chen; Jie Liu; Yu Mu; Fangfang Yuan; Wenjing Liu; Yanqiu Zhao
Journal:  Cell Death Dis       Date:  2020-09-25       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.